References
- Dixey J. Erythema nodosum. In: Klippel JH, Dieppe PA, eds. Rheumatology. St Louis: Mosby Year Book Europe, 1994;6: 24.2–24.4.
- Winkelmann RK, Forstrom L. New observations in the histo-pathology of erythema nodosum. J Invest Dermatol 1975;65:441–6.
- Schorr-Lesnick B, Brandt U. Selected rheumatologic and der-matologic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988;83:216–23.
- Atanes S, Gomez N, Aspe B, de Toro J, Grana J, Sanchez JM, et al. Eritema nudoso: estudio de 160 casos. Med Clin (Barc) 1991;34: 159–65.
- Magro CM, Crowson AN. Cutaneous manifestations of Behçet's disease. Int J Dermatol 1995;34:159–65.
- Bombardieri S, Di Munno O, Di Punzo C, Pasero G. Erythema nodosum associated with pregnancy and oral contraceptives. Br Med J 1977;11:1509–10.
- Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 1994;19:7–21.
- Johnson ML, Wilson HT. Skin lesions in ulcerative colitis. Gut 1969;10:255–63.
- Danzi JT. Extraintestinal manifestations of idiopathic bowel disease. Arch Intern Med 1988;148:297–302.
- Kone Paut I, Yurdakul S, Bahabri S, Shafae N, Ozen S, Ozdogan H, et al. Clinical features of Behçet disease in children: an international collaborative study of 86 cases. J Pediatr 1998;132:721–5.
- Likaner BD. Erythema nodosum presenting before inflamma-tory bowel disease. Lancet 1977;2:931–2.
- Gattorno M, Picco P, Buoncompagni A, Stalla F, Facchetti P, Sormani MP, et al. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Ann Rheum Dis 1996;55:243–7.
- International study group for Behçet's disease. Criteria for diagnosis of BelKet's disease. Lancet 1990;335:1078–80.
- Lie JT. Vascular involvement in Behçet's syndrome: arterial and venous and vessels of all sizes. J Rheumatol 1992;19:341–3.
- Wilkenstein JA, Sullivan KE, Colten HR. Genetically deter-minated disorders of the complement. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecu-lar bases o f inherited diseases. 7th ed. New York: McGraw-Hill Inc, 1995:3911–41.
- Chung SI, Su WPD, Lee S, Rogers III RS. Erythema nodosum-like lesions in Behçet's syndrome: a histopathologic study of 30 cases. J Cutan Pathol 1989;16: 259–65.
- Thomas DW, Sinatra FR, Merritt RJ. Random fecal alpha 1 antitrypsin concentration in children with gastrointestinal dis-ease. Gastroenterology 1981;80: 776–82.
- Goldblum RM, Hanson LA, Brandtzaeg. The mucosal defense system. In: Stiehm ER ed. Immunologic disorders in infants and children.4thed.Philadelphia:WBSaunders,1996:159–99.
- Lorber J. The changing etiology of erythema nodosum in chil-dren. Arch Dis Child 1958;33:137–41.
- Picco P, Buoncompagni A. La malattia di Behget. Riv It Ped 1998;24:67–70.
- Johnson KJ, Ward PA, Kunkel RG. Mediation of IgA induced lung injury in the rat. Role of the macrophage and reactive oxy-gen products. Lab Invest 1986;54:499–506.
- Gattorno M, Picco P, Barbano GC, Stalla F, Sormani MP, Buoncompagni A, et al. Differences in TNFa soluble receptors serum concentration between Schoenlein-Henoch purpura and pediatric SLE. Possible pathogenetic implications. J Rheuma-tol 1998;25:361–5.
- Bruneau C, Villiaumey J, Avouac B, Martigny J, Laurent J, Pichot A, et al. Serum negative spondyloarthropathies and IgA glomerulonephritis: a report of four cases and a review of the literature. Semin Arthritis Rheum 1986;15:179–83.